- Citations, last 5 years
- 126
- Works, last 5 years
- 11
- h-index
- 69
- Scientists listed
- 2
- Grants since 2016
- 51
Grants received
2025–2026 · contract · N02
REGULATORY SERVICES AND TECHNICAL SUPPORT TO THE DIVISION OF CANCER PREVENTION (DCP)
Caroline Sigman · CCS Associates (United States) · funded by National Institutes of Health
2025–2026 · contract · N02
PROVIDE A VARIETY OF CRITICAL CANCER PREVENTION INFORMATION MANAGEMENT FUNCTIONS
Caroline Sigman · CCS Associates (United States) · funded by National Institutes of Health
2023–2024 · contract · N01
Vendor Audit Support Through the Comprehensive and Rapid Response to NIAID Research Programs (CARRRP) Contract
Robert Brakaj · CCS Associates (United States) · funded by National Institutes of Health
2023–2024 · contract · N02
MEDICAL WRITING CONSULTING SERVICES
Dirk Mandel · CCS Associates (United States) · funded by National Institutes of Health
2023–2025 · contract · N02
MEDICAL WRITING CONSULTING SERVICES
Caroline C Sigman · CCS Associates (United States) · funded by National Institutes of Health
2023–2024 · contract · N02
PROVIDE A VARIETY OF CRITICAL CANCER PREVENTION INFORMATION MANAGEMENT FUNCTIONS
Caroline Sigman · CCS Associates (United States) · funded by National Institutes of Health
2023–2024 · contract · N02
REGULATORY AFFAIRS CONSULTING SUPPORT SERVICES
Lynn Thomas · CCS Associates (United States) · funded by National Institutes of Health
2023–2025 · contract · N02
PROVIDE A VARIETY OF CRITICAL CANCER PREVENTION INFORMATION MANAGEMENT FUNCTIONS
Caroline Sigman · CCS Associates (United States) · funded by National Institutes of Health
2023–2025 · contract · N02
REGULATORY SERVICES AND TECHNICAL SUPPORT TO THE DIVISION OF CANCER PREVENTION (DCP)
Caroline Sigman · CCS Associates (United States) · funded by National Institutes of Health
2023–2024 · contract · N02
THE PURPOSE OF THIS REQUIREMENT IS TO PROVIDE REGULATORY SERVICES AND TECHNICAL SUPPORT TO THE DIVISION OF CANCER PREVENTION (DCP) AT THE NATIONAL CANCER INSTITUTE (NCI). NCI AND DCP HAVE A RECURRING
Caroline Sigman · CCS Associates (United States) · funded by National Institutes of Health
2023–2024 · contract · N02
REGULATORY AFFAIRS CONSULTING SUPPORT SERVICES
Lynn Thomas · CCS Associates (United States) · funded by National Institutes of Health
2023–2025 · contract · N02
MEDICAL WRITING CONSULTING SERVICES
Dirk Mandel · CCS Associates (United States) · funded by National Institutes of Health
2023–2024 · contract · N02
REGULATORY AFFAIRS CONSULTING SUPPORT SERVICES
Lynn Thomas · CCS Associates (United States) · funded by National Institutes of Health
2023–2025 · contract · N02
MEDICAL WRITING CONSULTING SERVICES
Caroline C Sigman · CCS Associates (United States) · funded by National Institutes of Health
2023–2025 · contract · N02
MEDICAL WRITING CONSULTING SERVICES
Dirk Mandel · CCS Associates (United States) · funded by National Institutes of Health
2023–2025 · contract · N02
REGULATORY AFFAIRS CONSULTING SUPPORT SERVICES
Lynn Thomas · CCS Associates (United States) · funded by National Institutes of Health
2022–2023 · contract · N02
REGULATORY AFFAIRS CONSULTING SUPPORT SERVICES
Caroline Sigman · CCS Associates (United States) · funded by National Institutes of Health
2022–2023 · contract · N02
REGULATORY AFFAIRS CONSULTING SUPPORT SERVICES
Caroline Sigman · CCS Associates (United States) · funded by National Institutes of Health
2022–2023 · contract · N02
PREPARATION OF AN INVESTIGATIONAL NEW DRUG (IND) APPLICATION WITH FOOD AND DRUG ADMINISTRATION (FDA) FOR A TREATMENT FOR JANSEN'S METAPHYSEAL CHONDRODYSPLASIA
Robert Brakaj · CCS Associates (United States) · funded by National Institutes of Health
2022–2023 · contract · N02
Regulatory Support for Cancer Prevention Agent Development
Caroline Sigman · CCS Associates (United States) · funded by National Institutes of Health
2021 · contract · N02
REGULATORY AFFAIRS CONSULTING SUPPORT SERVICES
Caroline Sigman · CCS Associates (United States) · funded by National Institutes of Health
2021–2024 · cooperative agreement · U01
DDTBMQ000011: Advance tumor volume change as measured by CT as a pharmacodynamic biomarker for new oncologic drug clinical trial therapy of solid tumors to Stage 2 of FDA biomarker qualification
Ying Tang · CCS Associates (United States) · funded by U.S. Food and Drug Administration
2021–2022 · contract · N02
Regulatory Support for Cancer Prevention Agent Development
Caroline Sigman · CCS Associates (United States) · funded by National Institutes of Health
2021 · contract · N02
REGULATORY AFFAIRS CONSULTING SUPPORT SERVICES
Caroline Sigman · CCS Associates (United States) · funded by National Institutes of Health
2021 · contract · N02
REGULATORY AFFAIRS CONSULTING SUPPORT SERVICES
Caroline Sigman · CCS Associates (United States) · funded by National Institutes of Health
2021 · contract · N02
MEDICAL WRITING CONSULTING AND DRUG DOSSIER DEVELOPMENT SUPPORT SERVICES
Caroline Sigman · CCS Associates (United States) · funded by National Institutes of Health
2021–2022 · contract · N02
Technical Information Research Resources for Cancer Preventive Agent Development
Caroline Sigman · CCS Associates (United States) · funded by National Institutes of Health
2020–2023 · contract · N02
MEDICAL WRITING CONSULTING AND DRUG DOSSIER DEVELOPMENT SUPPORT SERVICES
Caroline Sigman · CCS Associates (United States) · funded by National Institutes of Health
2020–2021 · contract · N02
Regulatory Support for Cancer Prevention Agent Development
Caroline Sigman · CCS Associates (United States) · funded by National Institutes of Health
2020–2021 · contract · N02
Technical Information Research Resources for Cancer Preventive Agent Development
Caroline Sigman · CCS Associates (United States) · funded by National Institutes of Health
2020 · contract · N02
MEDICAL WRITING CONSULTING AND DRUG DOSSIER DEVELOPMENT SUPPORT SERVICES
Caroline Sigman · CCS Associates (United States) · funded by National Institutes of Health
2020 · contract · N02
REGULATORY AFFAIRS CONSULTING SUPPORT SERVICES
Caroline Sigman · CCS Associates (United States) · funded by National Institutes of Health
2020–2023 · contract · N02
MEDICAL WRITING CONSULTING AND DRUG DOSSIER DEVELOPMENT SUPPORT SERVICES
Caroline Sigman · CCS Associates (United States) · funded by National Institutes of Health
2019–2020 · contract · N02
Regulatory Support for Cancer Prevention Agent Development
Caroline Sigman · CCS Associates (United States) · funded by National Institutes of Health
2019–2020 · contract · N02
Technical Information Research Resources for Cancer Preventive Agent Development
Caroline Sigman · CCS Associates (United States) · funded by National Institutes of Health
2018–2023 · contract · N02
Technical Information Research Resources for Cancer Preventive Agent Development
Caroline Sigman · CCS Associates (United States) · funded by National Institutes of Health
2018–2019 · contract · N02
NINDS BPN REGULATORY AFFAIRS CONSULTANT CCS ASSOCIATES IGF::CL::IGF
Karen Hansen · CCS Associates (United States) · funded by National Institutes of Health
2018–2019 · contract · N02
NINDS BPN MEDICAL WRITING CONSULTANT IGF::CL::IGF
Karen Hansen · CCS Associates (United States) · funded by National Institutes of Health
2018–2019 · contract · N01
Regulatory Support for Cancer Prevention Agent Development
Caroline Sigman · CCS Associates (United States) · funded by National Institutes of Health
2018–2019 · contract · N01
Technical Information Research Resources for Cancer Preventive Agent Development
(Contact) · CCS Associates (United States) · funded by National Institutes of Health